Friday, July 14, 2017

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 9

If you are unable to see the message below, click here to view.


Volume 42, Issue 9 (August 2017)

In this issue
Original Articles
Follow NPP on Facebook Facebook

Follow NPP on Twitter Twitter

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



Strained in Planning Your Mouse Background? Using the HPA Stress Axis as a Biological Readout for Backcrossing Strategies

Jennifer C Chan, Amanda B Houghton and Tracy L Bale

Neuropsychopharmacology 2017 42: 1749-1751; advance online publication, March 31, 2017; 10.1038/npp.2017.66

Full Text



Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Suzanne Nielsen, Pamela Sabioni, Jose M Trigo, Mark A Ware, Brigid D Betz-Stablein, Bridin Murnion, Nicholas Lintzeris, Kok Eng Khor, Michael Farrell, Andrew Smith and Bernard Le Foll

Neuropsychopharmacology 2017 42: 1752-1765; advance online publication, March 22, 2017; 10.1038/npp.2017.51

Abstract | Full Text

Original Articles


Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial

Brenna C McDonald, Laura A Flashman, David B Arciniegas, Robert J Ferguson, Li Xing, Jaroslaw Harezlak, Gwen C Sprehn, Flora M Hammond, Arthur C Maerlender, Carrie L Kruck, Karen L Gillock, Kim Frey, Rachel N Wall, Andrew J Saykin and Thomas W McAllister

Neuropsychopharmacology 2017 42: 1766-1775; advance online publication, November 22, 2016; 10.1038/npp.2016.261

Abstract | Full Text

Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

Lara A Ray, Spencer Bujarski, Steve Shoptaw, Daniel JO Roche, Keith Heinzerling and Karen Miotto

Neuropsychopharmacology 2017 42: 1776-1788; advance online publication, January 16, 2017; 10.1038/npp.2017.10

Abstract | Full Text

The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats

Eric Augier, Russell S Dulman, Ruslan Damadzic, Andrew Pilling, J Paul Hamilton and Markus Heilig

Neuropsychopharmacology 2017 42: 1789-1799; advance online publication, March 15, 2017; 10.1038/npp.2017.53

Abstract | Full Text

Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability

Sudarat Nimitvilai, Marcelo F Lopez, Patrick J Mulholland and John J Woodward

Neuropsychopharmacology 2017 42: 1800-1812; advance online publication, January 31, 2017; 10.1038/npp.2017.22

Abstract | Full Text

Ethanol Withdrawal Drives Anxiety-Related Behaviors by Reducing M-type Potassium Channel Activity in the Lateral Habenula

Seungwoo Kang, Jing Li, Wanhong Zuo, Rao Fu, Danielle Gregor, Kresimir Krnjevic, Alex Bekker and Jiang-Hong Ye

Neuropsychopharmacology 2017 42: 1813-1824; advance online publication, April 7, 2017; 10.1038/npp.2017.68

Abstract | Full Text

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Verena E Metz, Jermaine D Jones, Jeanne Manubay, Maria A Sullivan, Shanthi Mogali, Andrew Segoshi, Gabriela Madera, Kirk W Johnson and Sandra D Comer

Neuropsychopharmacology 2017 42: 1825-1832; advance online publication, April 10, 2017; 10.1038/npp.2017.70

Abstract | Full Text

Opioid Modulation of Value-Based Decision-Making in Healthy Humans

Marie Eikemo, Guido Biele, Frode Willoch, Lotte Thomsen and Siri Leknes

Neuropsychopharmacology 2017 42: 1833-1840; advance online publication, March 15, 2017; 10.1038/npp.2017.58

Abstract | Full Text

Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement

Giovanni C Santoro, Joseph Carrion, Krishna Patel, Crystal Vilchez, Jennifer Veith, Jonathan D Brodie and Stephen L Dewey

Neuropsychopharmacology 2017 42: 1841-1849; advance online publication, April 10, 2017; 10.1038/npp.2017.69

Abstract | Full Text

High-Frequency Stimulation of the Subthalamic Nucleus Blocks Compulsive-Like Re-Escalation of Heroin Taking in Rats

Carrie L Wade, Marsida Kallupi, Daniel O Hernandez, Emmanuel Breysse, Giordano de Guglielmo, Elena Crawford, George F Koob, Paul Schweitzer, Christelle Baunez and Olivier George

Neuropsychopharmacology 2017 42: 1850-1859; advance online publication, December 5, 2016; 10.1038/npp.2016.270

Abstract | Full Text

Glutamatergic Projections from the Entorhinal Cortex to Dorsal Dentate Gyrus Mediate Context-Induced Reinstatement of Heroin Seeking OPEN

Feifei Ge, Na Wang, Cailian Cui, Yijing Li, Yan Liu, Yaoying Ma, Shuli Liu, Haolin Zhang and Xiaowei Sun

Neuropsychopharmacology 2017 42: 1860-1870; advance online publication, January 20, 2017; 10.1038/npp.2017.14

Abstract | Full Text

The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic

Hai-Ying Zhang, Guo-Hua Bi, Hong-Ju Yang, Yi He, Gilbert Xue, Jiajing Cao, Gianluigi Tanda, Eliot L Gardner, Amy Hauck Newman and Zheng-Xiong Xi

Neuropsychopharmacology 2017 42: 1871-1883; advance online publication, March 7, 2017; 10.1038/npp.2017.41

Abstract | Full Text

Garcinol Blocks the Reconsolidation of Multiple Cocaine-Paired Cues after a Single Cocaine-Reactivation Session

Amber B Dunbar and Jane R Taylor

Neuropsychopharmacology 2017 42: 1884-1892; advance online publication, February 7, 2017; 10.1038/npp.2017.27

Abstract | Full Text

Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration

Cody A Siciliano and Sara R Jones

Neuropsychopharmacology 2017 42: 1893-1904; advance online publication, January 31, 2017; 10.1038/npp.2017.24

Abstract | Full Text

Associations Between Behavioral and Neural Correlates of Inhibitory Control and Amphetamine Reward Sensitivity

Jessica Weafer, Stephanie M Gorka, Donald Hedeker, Mario Dzemidzic, David A Kareken, K Luan Phan and Harriet de Wit

Neuropsychopharmacology 2017 42: 1905-1913; advance online publication, March 17, 2017; 10.1038/npp.2017.61

Abstract | Full Text

A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder OPEN

Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl and Paulo Fontoura

Neuropsychopharmacology 2017 42: 1914-1923; advance online publication, October 6, 2016; 10.1038/npp.2016.232

Abstract | Full Text



A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder

Daniel Umbricht, Marta del Valle Rubido, Eric Hollander, James T McCracken, Frederick Shic, Lawrence Scahill, Jana Noeldeke, Lauren Boak, Omar Khwaja, Lisa Squassante, Christophe Grundschober, Heidemarie Kletzl and Paulo Fontoura

Neuropsychopharmacology 2017 42: 1924; 10.1038/npp.2017.92

Full Text

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence

Anna Murphy, Liam J Nestor, John McGonigle, Louise Paterson, Venkataramana Boyapati, Karen D Ersche, Remy Flechais, Shankar Kuchibatla, Antonio Metastasio, Csaba Orban, Filippo Passetti, Laurence Reed, Dana Smith, John Suckling, Eleanor Taylor, Trevor W Robbins, Anne Lingford-Hughes, David J Nutt, John F W Deakin, Rebecca Elliott and ICCAM Platform

Neuropsychopharmacology 2017 42: 1925-1926; 10.1038/npp.2017.99

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: